Glycine N-methyltransferase deficiency: A novel inborn error causing persistent isolated hypermethioninaemia

S. H. Mudd, R. Cerone, M. C. Schiaffino, A. R. Fantasia, G. Minniti, U. Caruso, R. Lorini, D. Watkins, N. Matiaszuk, D. S. Rosenblatt, B. Schwahn, R. Rozen, L. LeGros, M. Kotb, A. Capdevila, Z. Luka, J. D. Finkelstein, A. Tangerman, S. P. Stabler, R. H. AllenC. Wagner

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

This paper reports clinical and metabolic studies of two Italian siblings with a novel form of persistent isolated hypermethioninaemia, i.e. abnormally elevated plasma methionine that lasted beyond the first months of life and is not due to cystathionine β-synthase deficiency, tyrosinaemia I or liver disease. Abnormal elevations of their plasma S-adenosylmethionine (AdoMet) concentrations proved they do not have deficient activity of methionine adenosyltransferase I/III. A variety of studies provided evidence that the elevations of methionine and AdoMet are not caused by defects in the methionine transamination pathway, deficient activity of methionine adenosyltransferase II, a mutation in methylenetetrahydrofolate reductase rendering this activity resistant to inhibition by AdoMet, or deficient activity of guanidinoacetate methyltransferase. Plasma sarcosine (N-methylglycine) is elevated, together with elevated plasma AdoMet in normal subjects following oral methionine loads and in association with increased plasma levels of both methionine and AdoMet in cystathionine β-synthase-deficient individuals. However, plasma sarcosine is not elevated in these siblings. The latter result provides evidence they are deficient in activity of glycine N-methyltransferase (GNMT). The only clinical abnormalities in these siblings are mild hepatomegaly and chronic elevation of serum transaminases not attributable to conventional causes of liver disease. A possible causative connection between GNMT deficiency and these hepatitis-like manifestations is discussed. Further studies are required to evaluated whether dietary methionine restriction will be useful in this situation.

Original languageEnglish
Pages (from-to)448-464
Number of pages17
JournalJournal of Inherited Metabolic Disease
Volume24
Issue number4
DOIs
Publication statusPublished - 2001

Fingerprint

S-Adenosylmethionine
Methionine
Sarcosine
Methionine Adenosyltransferase
Cystathionine
Liver Diseases
Guanidinoacetate N-Methyltransferase
Glycine N-Methyltransferase
Tyrosinemias
Methylenetetrahydrofolate Reductase (NADPH2)
Hepatomegaly
Transaminases
Hepatitis
Hypermethioninemia
Mutation
Serum

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics
  • Endocrinology

Cite this

Glycine N-methyltransferase deficiency : A novel inborn error causing persistent isolated hypermethioninaemia. / Mudd, S. H.; Cerone, R.; Schiaffino, M. C.; Fantasia, A. R.; Minniti, G.; Caruso, U.; Lorini, R.; Watkins, D.; Matiaszuk, N.; Rosenblatt, D. S.; Schwahn, B.; Rozen, R.; LeGros, L.; Kotb, M.; Capdevila, A.; Luka, Z.; Finkelstein, J. D.; Tangerman, A.; Stabler, S. P.; Allen, R. H.; Wagner, C.

In: Journal of Inherited Metabolic Disease, Vol. 24, No. 4, 2001, p. 448-464.

Research output: Contribution to journalArticle

Mudd, SH, Cerone, R, Schiaffino, MC, Fantasia, AR, Minniti, G, Caruso, U, Lorini, R, Watkins, D, Matiaszuk, N, Rosenblatt, DS, Schwahn, B, Rozen, R, LeGros, L, Kotb, M, Capdevila, A, Luka, Z, Finkelstein, JD, Tangerman, A, Stabler, SP, Allen, RH & Wagner, C 2001, 'Glycine N-methyltransferase deficiency: A novel inborn error causing persistent isolated hypermethioninaemia', Journal of Inherited Metabolic Disease, vol. 24, no. 4, pp. 448-464. https://doi.org/10.1023/A:1010577512912
Mudd, S. H. ; Cerone, R. ; Schiaffino, M. C. ; Fantasia, A. R. ; Minniti, G. ; Caruso, U. ; Lorini, R. ; Watkins, D. ; Matiaszuk, N. ; Rosenblatt, D. S. ; Schwahn, B. ; Rozen, R. ; LeGros, L. ; Kotb, M. ; Capdevila, A. ; Luka, Z. ; Finkelstein, J. D. ; Tangerman, A. ; Stabler, S. P. ; Allen, R. H. ; Wagner, C. / Glycine N-methyltransferase deficiency : A novel inborn error causing persistent isolated hypermethioninaemia. In: Journal of Inherited Metabolic Disease. 2001 ; Vol. 24, No. 4. pp. 448-464.
@article{2aeac882d3a24920b75efc610519f44b,
title = "Glycine N-methyltransferase deficiency: A novel inborn error causing persistent isolated hypermethioninaemia",
abstract = "This paper reports clinical and metabolic studies of two Italian siblings with a novel form of persistent isolated hypermethioninaemia, i.e. abnormally elevated plasma methionine that lasted beyond the first months of life and is not due to cystathionine β-synthase deficiency, tyrosinaemia I or liver disease. Abnormal elevations of their plasma S-adenosylmethionine (AdoMet) concentrations proved they do not have deficient activity of methionine adenosyltransferase I/III. A variety of studies provided evidence that the elevations of methionine and AdoMet are not caused by defects in the methionine transamination pathway, deficient activity of methionine adenosyltransferase II, a mutation in methylenetetrahydrofolate reductase rendering this activity resistant to inhibition by AdoMet, or deficient activity of guanidinoacetate methyltransferase. Plasma sarcosine (N-methylglycine) is elevated, together with elevated plasma AdoMet in normal subjects following oral methionine loads and in association with increased plasma levels of both methionine and AdoMet in cystathionine β-synthase-deficient individuals. However, plasma sarcosine is not elevated in these siblings. The latter result provides evidence they are deficient in activity of glycine N-methyltransferase (GNMT). The only clinical abnormalities in these siblings are mild hepatomegaly and chronic elevation of serum transaminases not attributable to conventional causes of liver disease. A possible causative connection between GNMT deficiency and these hepatitis-like manifestations is discussed. Further studies are required to evaluated whether dietary methionine restriction will be useful in this situation.",
author = "Mudd, {S. H.} and R. Cerone and Schiaffino, {M. C.} and Fantasia, {A. R.} and G. Minniti and U. Caruso and R. Lorini and D. Watkins and N. Matiaszuk and Rosenblatt, {D. S.} and B. Schwahn and R. Rozen and L. LeGros and M. Kotb and A. Capdevila and Z. Luka and Finkelstein, {J. D.} and A. Tangerman and Stabler, {S. P.} and Allen, {R. H.} and C. Wagner",
year = "2001",
doi = "10.1023/A:1010577512912",
language = "English",
volume = "24",
pages = "448--464",
journal = "Journal of Inherited Metabolic Disease",
issn = "0141-8955",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - Glycine N-methyltransferase deficiency

T2 - A novel inborn error causing persistent isolated hypermethioninaemia

AU - Mudd, S. H.

AU - Cerone, R.

AU - Schiaffino, M. C.

AU - Fantasia, A. R.

AU - Minniti, G.

AU - Caruso, U.

AU - Lorini, R.

AU - Watkins, D.

AU - Matiaszuk, N.

AU - Rosenblatt, D. S.

AU - Schwahn, B.

AU - Rozen, R.

AU - LeGros, L.

AU - Kotb, M.

AU - Capdevila, A.

AU - Luka, Z.

AU - Finkelstein, J. D.

AU - Tangerman, A.

AU - Stabler, S. P.

AU - Allen, R. H.

AU - Wagner, C.

PY - 2001

Y1 - 2001

N2 - This paper reports clinical and metabolic studies of two Italian siblings with a novel form of persistent isolated hypermethioninaemia, i.e. abnormally elevated plasma methionine that lasted beyond the first months of life and is not due to cystathionine β-synthase deficiency, tyrosinaemia I or liver disease. Abnormal elevations of their plasma S-adenosylmethionine (AdoMet) concentrations proved they do not have deficient activity of methionine adenosyltransferase I/III. A variety of studies provided evidence that the elevations of methionine and AdoMet are not caused by defects in the methionine transamination pathway, deficient activity of methionine adenosyltransferase II, a mutation in methylenetetrahydrofolate reductase rendering this activity resistant to inhibition by AdoMet, or deficient activity of guanidinoacetate methyltransferase. Plasma sarcosine (N-methylglycine) is elevated, together with elevated plasma AdoMet in normal subjects following oral methionine loads and in association with increased plasma levels of both methionine and AdoMet in cystathionine β-synthase-deficient individuals. However, plasma sarcosine is not elevated in these siblings. The latter result provides evidence they are deficient in activity of glycine N-methyltransferase (GNMT). The only clinical abnormalities in these siblings are mild hepatomegaly and chronic elevation of serum transaminases not attributable to conventional causes of liver disease. A possible causative connection between GNMT deficiency and these hepatitis-like manifestations is discussed. Further studies are required to evaluated whether dietary methionine restriction will be useful in this situation.

AB - This paper reports clinical and metabolic studies of two Italian siblings with a novel form of persistent isolated hypermethioninaemia, i.e. abnormally elevated plasma methionine that lasted beyond the first months of life and is not due to cystathionine β-synthase deficiency, tyrosinaemia I or liver disease. Abnormal elevations of their plasma S-adenosylmethionine (AdoMet) concentrations proved they do not have deficient activity of methionine adenosyltransferase I/III. A variety of studies provided evidence that the elevations of methionine and AdoMet are not caused by defects in the methionine transamination pathway, deficient activity of methionine adenosyltransferase II, a mutation in methylenetetrahydrofolate reductase rendering this activity resistant to inhibition by AdoMet, or deficient activity of guanidinoacetate methyltransferase. Plasma sarcosine (N-methylglycine) is elevated, together with elevated plasma AdoMet in normal subjects following oral methionine loads and in association with increased plasma levels of both methionine and AdoMet in cystathionine β-synthase-deficient individuals. However, plasma sarcosine is not elevated in these siblings. The latter result provides evidence they are deficient in activity of glycine N-methyltransferase (GNMT). The only clinical abnormalities in these siblings are mild hepatomegaly and chronic elevation of serum transaminases not attributable to conventional causes of liver disease. A possible causative connection between GNMT deficiency and these hepatitis-like manifestations is discussed. Further studies are required to evaluated whether dietary methionine restriction will be useful in this situation.

UR - http://www.scopus.com/inward/record.url?scp=0034827802&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034827802&partnerID=8YFLogxK

U2 - 10.1023/A:1010577512912

DO - 10.1023/A:1010577512912

M3 - Article

C2 - 11596649

AN - SCOPUS:0034827802

VL - 24

SP - 448

EP - 464

JO - Journal of Inherited Metabolic Disease

JF - Journal of Inherited Metabolic Disease

SN - 0141-8955

IS - 4

ER -